SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRcb 5% Regulatory News (GHT2)

Share Price Information for Rcb 5% (GHT2)

Share Price is delayed by 15 minutes
Get Live Data
90.80    0.00 (0.00%)
Bid:
88.10
Ask:
93.50
Spread: 5.40 (6.129%)
Market Cap: -
GHT2 Live PriceLast checked at - London Stock Exchange

Intraday Rcb 5% Share Chart

Result of Tender Offer

19 Mar 2026 15:55

RNS Number : 3723X
RCB Bonds PLC
19 March 2026
 

DISCLAIMER - INTENDED ADDRESSEES

 

THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE MARKET ABUSE REGULATION (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (THE UK MARKET ABUSE REGULATION)

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OF AMERICA OR THE DISTRICT OF COLUMBIA (THE UNITED STATES) OR ANY OTHER JURISDICTION OR TO ANY OTHER PERSON WHERE OR TO WHOM IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT

 

 

19 March 2026

 

RCB Bonds PLC announces final results of tender offer

made by Greensleeves Homes Trust for RCB Bonds PLC's £50,000,000 4.25 per cent. Bonds due 2026 secured on a loan to Greensleeves Homes Trust

 

RCB Bonds PLC (the Issuer) today announces the final results of the invitation made by Greensleeves Homes Trust (the Offeror) to holders (the Bondholders) of the Issuer's outstanding £50,000,000 4.25 per cent. Bonds due 2026 secured on a loan to the Offeror and bearing ISIN: XS1575974933 (the Bonds) to tender such Bonds for purchase by the Offeror for cash up to the Maximum Acceptance Amount subject to the satisfaction (or waiver) of the New Financing Condition and the other conditions described in the Tender Offer Memorandum (as defined below) (the Offer).

 

The Offer was announced by the Issuer on 20 February 2026 and was made on the terms and subject to the conditions contained in the tender offer memorandum dated 20 February 2026 (the Tender Offer Memorandum) prepared by the Offeror and communicated to the Bondholders by the Issuer.

 

Capitalised terms used in this announcement but not defined have the meanings given to them in the Tender Offer Memorandum.

 

Participation as at the Expiration Deadline

 

The Expiration Deadline of the Offer was 4.00 p.m. (London time) on 18 March 2026. As at the Expiration Deadline, the Offeror had received valid Tender Instructions in respect of £28,921,900 in aggregate principal amount of the Bonds.

 

Results of the Offer

 

As described in the issue size announcement made by the Issuer dated 19 March 2026, the gross proceeds of the New Bonds (excluding any retained bonds) to be issued is £23,216,174, and accordingly the Maximum Acceptance Amount (being the lower of (i) such gross proceeds divided by the Purchase Price of 97 per cent. and (ii) £30,000,000) is £23,934,200, although, as set out in the Tender Offer Memorandum, the Offeror has sole discretion to accept an amount more or less than the Maximum Acceptance Amount (or to accept none of the Bonds for purchase).

 

The Offeror has determined that the Final Acceptance Amount shall be £21,547,400. Accordingly, subject to the satisfaction (or waiver) of the New Financing Condition the Offeror will accept for purchase at the Purchase Price all Priority Bonds that are the subject of valid Tender Instructions, being £21,547,400 in principal amount of the Bonds. The Offeror will also pay an Accrued Interest Payment in respect of such Priority Bonds, as described in the Tender Offer Memorandum.

 

No Tender Only Bonds will be accepted for purchase.

 

£28,452,600 in aggregate principal amount of the Bonds will remain outstanding following settlement of the Offer. As announced by the Issuer on 3 February 2026, the redemption of the outstanding Bonds (and, accordingly, the payment of such amount) shall be deferred in accordance with Condition 10.3 of the Bonds until 30 March 2028.

 

The expected Settlement Date for the Offer, subject to satisfaction (or waiver) of the New Financing Condition, is 25 March 2026. As at the date of this announcement, the New Financing Condition has neither been satisfied nor waived.

 

 

Dealer Manager

Allia C&C Ltd

Henrietta Podd

+44 20 3039 3452

Tender Agent

Kroll Issuer Services Limited

Owen Morris

+44 20 7704 0880

 

 

 

Questions and requests for assistance in connection with the Offer may be directed to the Dealer Manager whose contact details are set out above.

 

This announcement contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the UK Market Abuse Regulation, encompassing information relating to the Offer described above. For the purposes of the UK Market Abuse Regulation, this announcement is made by John Tattersall, Chair, RCB Bonds PLC.

 

LEI Number: 21380081925ENBZ6KM68

 

DISCLAIMER This announcement must be read in conjunction with the Tender Offer Memorandum. The distribution of this announcement and the Tender Offer Memorandum in certain jurisdictions may be restricted by law. Persons into whose possession this announcement and/or the Tender Offer Memorandum comes are required by each of the Offeror, the Issuer, the Dealer Manager and the Tender Agent to inform themselves about, and to observe, any such restrictions.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTEEKLFFQXLZBBQ
Date   Source Headline
26th Mar 202610:02 amRNSAdmission to trading
19th Mar 20263:55 pmRNSResult of Tender Offer
19th Mar 20263:54 pmRNSIssue size announcement
20th Feb 202612:50 pmRNSPublication of a Prospectus
20th Feb 202612:49 pmRNSTender Offer for Greensleeves 4.25% Bonds due 2026
3rd Feb 20268:34 amRNSGreensleeves Care Announcements
3rd Feb 20268:34 amRNSGreensleeves Care Trading Statement
22nd Dec 202512:44 pmRNSGreensleeves Care Investor Update
22nd Dec 202512:44 pmRNSGreensleeves Care Investor Update
28th Oct 202510:13 amRNSGreensleeves Homes Trust - Social Impact Report
23rd Oct 202510:35 amRNSGreensleeves Homes Trust - Investor Update
25th Sep 20251:45 pmRNSGreensleeves Homes Trust Financial Statements
29th Aug 20251:20 pmRNSGreensleeves Care - CEO Update & Trading Statement
30th Jan 20252:43 pmRNSGreensleeves Homes Trust Roadshow Announcement
29th Jan 20252:29 pmRNSGreensleeves Care Trading Statement
9th Dec 20247:11 amRNSGreensleeves Trading Statement
3rd Dec 20242:14 pmRNSGreensleeves Care - Senior Executive Change
25th Sep 202411:24 amRNSGreensleeves Care - Investor Update
20th Sep 20243:15 pmRNSGreensleeves Care Social Impact & Investor Update
1st Aug 20243:22 pmRNSGreensleeves Homes Trust - Annual Financial Report
23rd Jul 202412:23 pmRNSGreensleeves Homes Trust Trading Statement
15th Nov 20233:59 pmRNSGREENSLEEVES HOMES TRUST TRADING STATEMENT
28th Sep 20232:43 pmRNSGreensleeves Homes Trust Financial Statements
22nd Aug 20232:47 pmRNSGreensleeves Homes Trust Trading Statement
27th Sep 202211:58 amRNSGreensleeves Homes Trust financial statements
22nd Dec 202110:05 amRNSGreensleeves Homes Trust Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.